When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Breakthrough antidepressants with fewer side effects could ...

   www.aol.com/finance/breakthrough-antidepressants...

   As Americans are increasingly reaching for pharmaceutical solutions for depression—about one in eight U.S. adults takes antidepressants—scientists have been innovating novel treatments for it.

3. Quetiapine - Wikipedia

   en.wikipedia.org/wiki/Quetiapine

   Quetiapine, sold under the brand name Seroquel among others, is an atypical antipsychotic medication used in the treatment of schizophrenia, bipolar disorder, bipolar depression, and major depressive disorder.

4. FDA approves first fast-acting oral drug for clinical depression

   www.aol.com/news/fda-approves-first-fast-acting...

   Auvelity, from Axsome Therapeutics, marks the first drug with a different mechanism of action approved for treating depression in 60 years. In clinical trials, participants reported…

5. New antidepressants can lift depression and suicidal thoughts ...

   www.aol.com/news/antidepressants-lift-depression...

   Depression is the most common cause of disability in the world. Chances are high that you or someone you know will experience a period when depression gets in the way of work, social life or ...

6. Selective serotonin reuptake inhibitor - Wikipedia

   en.wikipedia.org/wiki/Selective_serotonin...

   Concomitant use of SSRIs or SNRIs for depression with a triptan for migraine does not appear to heighten the risk of the serotonin syndrome. [120] Taking monoamine oxidase inhibitors (MAOIs) in combination with SSRIs can be fatal, since MAOIs disrupt monoamine oxidase , an enzyme which is needed to break down serotonin and other neurotransmitters.

7. Amisulpride - Wikipedia

   en.wikipedia.org/wiki/Amisulpride

   Amisulpride is approved and used at low doses in the treatment of dysthymia and major depressive disorder. [10] [20] [11] [21] [22] [23] Whereas typical doses used in schizophrenia block postsynaptic dopamine D 2-like receptors and reduce dopaminergic neurotransmission, low doses of amisulpride preferentially block presynaptic dopamine D 2 and D 3 autoreceptors and thereby disinhibit dopamine ...